(Q72678975)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7910880%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

title

Regular vs as-needed inhaled salbutamol in asthma control (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7910880%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference

K R Chapman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7910880%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

S Kesten

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7910880%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

J P Szalai

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7910880%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

language of work or name

English

0 references

publication date

1 June 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7910880%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7910880%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

volume

343

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7910880%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

issue

8910

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7910880%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

page(s)

1379-1382

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7910880%20AND%20SRC:MED&resulttype=core&format=json

Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study

28 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2992520-8

7 January 2021

The use of beta-agonists and the risk of death and near death from asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2992520-8

7 January 2021

Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2992520-8

7 January 2021

Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2992520-8

7 January 2021

Regular inhaled salbutamol and airway responsiveness to allergen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2992520-8

7 January 2021

Comparison of four weeks' treatment with fenoterol and terbutaline aerosols in adult asthmatics *1A double-blind crossover study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2992520-8

7 January 2021

Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2992520-8

7 January 2021

Regular inhaled beta-agonist treatment in bronchial asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2992520-8

7 January 2021

Dose reduction of beta-agonists in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2992520-8

7 January 2021

A three-month comparison of twice daily inhaled formoterol versus four times daily inhaled albuterol in the management of stable asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2992520-8

7 January 2021

Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2992520-8

7 January 2021

Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2992520-8

7 January 2021

Tolerance to the nonbronchodilator effects of inhaled beta 2-agonists in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2992520-8

7 January 2021

Metered-dose inhaler adherence in a clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2992520-8

7 January 2021

Compliance of patients with asthma with an experimental aerosolized medication: implications for controlled clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2992520-8

7 January 2021

Regular inhaled beta agonist in asthma: effects on exacerbations and lung function

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2992520-8

7 January 2021

Beta agonists in asthma--state of the art: report on a Royal Society of Medicine seminar

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2992520-8

7 January 2021

Prolonged Protection against Methacholine-induced Bronchoconstriction by the Inhaled β2-Agonist Formoterol

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2992520-8

7 January 2021

10.1016/S0140-6736(94)92520-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7910880%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference